Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Unproven stem cell-based interventions and achieving a compromise policy among the multiple stakeholders.

BMC medical ethics - 4 Nov 2015

Matthews Kirstin R W, Iltis Ana S

Abstract excerpt

BACKGROUND: In 2004, patient advocate groups were major players in helping pass and implement significant public policy and funding initiatives in stem cells and regenerative medicine. In the following years, advocates were also actively engaged in Washington DC, encouraging policy makers to broaden embryonic stem cell research funding, which was ultimately passed after President Barack Obama came into office....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell- and Tissue-Based Therapy
Share to Government Regulation
Share to Health Policy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Infections

Share to Regenerative Medicine

Share to Stem Cell Transplantation

Share to United States

Share to United States Food and Drug Administration

Source

Open in PubMed Open full text

Identifiers

PMID: 26537611
DOI: 10.1186/s12910-015-0069-x
PMCID: PMC4634187

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Unproven stem cell-based interventions and achieving a compromise policy among the multiple stakeholders.PMID 26537611Read ↗

Safety issues in cell-based intervention trials.Semantic proximity Read ↗

Federal funding of human embryo stem cell research: advocating a broader approach.Semantic proximity Read ↗

Ethical and Practical Considerations for Cell and Gene Therapy Toward an HIV Cure: Findings from a Qualitative In-Depth Interview Study in the United StatesSemantic proximity Read ↗

A New Era in the Ethics of Human Embryonic Stem Cell ResearchSemantic proximity Read ↗

Stem Cell Policies in the United States and in GermanySemantic proximity Read ↗

Ethical Issues in Stem Cell ResearchSemantic proximity Read ↗

Can we do that here? An analysis of US federal and state policies guiding human embryo and embryoid researchSemantic proximity Read ↗

Adapting Preclinical Benchmarks for First-in-Human Trials of Human Embryonic Stem Cell-Based Therapies.Semantic proximity Read ↗

Diversity in Public Views Toward Stem Cell Sources and PoliciesSemantic proximity Read ↗

Regulation of Autologous Stem Cell Therapies: Report on Canadian Unsanctioned BusinessesSemantic proximity Read ↗

The Ethics of Human Stem Cell ResearchSemantic proximity Read ↗

Professional Perspectives on Dental Stem Cell Applications in Regenerative Dentistry: Knowledge, Attitudes, and Clinical ReadinessSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.